Indoco Remedies Share Price
249.01-5.43 (-2.13%)
-17.53% past 1 Year
Corporate filings & documents
Announcements
Pursuant to Regulation 30 of SEBI LODR the Committee of Executive Directors in its meeting held today i.e. 18th September 2026 has considered and approved the incorporation of the wholly owned subsidiary Warren Lifesciences Private Limited. The said company shall be incorporated in due course.
2 days agoPursuant to Regulation 30 of SEBI LODR the Committee of Executive Directors in its meeting held today i.e. 18th September 2026 has considered and approved the incorporation of the wholly owned subsidiary Warren Lifesciences Private Limited. The said company shall be incorporated in due course.
2 days agoPlease find enclosed herewith the details of Voting Results and Scrutinizers Report for the 79th AGM of the Company held on 17th September 2026
2 days agoPlease find enclosed herewith the details of Voting Results and Scrutinizers Report for the 79th AGM of the Company held on 17th September 2026
2 days agoWe are submitting herewith the details regarding the Proceedings of the 79th AGM of the Company held on Thursday 17th September 2026 at 10.30 am through video conferencing(VC)/other audio video means (OAVM)
3 days agoWe are submitting herewith the details regarding the Proceedings of the 79th AGM of the Company held on Thursday 17th September 2026 at 10.30 am through video conferencing(VC)/other audio video means (OAVM)
3 days agoUK MHRA inspection at Companys manufacturing facility at Plant I (solid oral dosage form) located at Goa.
1 week agoUK MHRA inspection at Companys manufacturing facility at Plant I (solid oral dosage form) located at Goa.
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
1 week agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
1 week agoUSFDA inspection at Companys manufacturing facility at Plant II (Sterile) located at Goa.
2 weeks agoUSFDA inspection at Companys manufacturing facility at Plant II (Sterile) located at Goa.
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Panandikar & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi Panandikar & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Aditi M Panandikar & Others
2 weeks agoIntimation of execution of Deed of Conveyance for Sale of Companys plot of land.
3 weeks agoIntimation of execution of Deed of Conveyance for Sale of Companys plot of land.
3 weeks agoNewspaper Advertisement-Information regarding 79th Annual General meeting and E-voting
4 weeks agoNewspaper Advertisement-Information regarding 79th Annual General meeting and E-voting
4 weeks agoBusiness Responsibility and Sustainability Reporting (BRSR)
1 month agoBusiness Responsibility and Sustainability Reporting (BRSR)
1 month agoAnnual Report for the financial year 2025-2026
1 month agoAnnual Report for the financial year 2025-2026
1 month agoNotice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026
1 month agoNotice of 79th Annual General Meeting and Annual Report for the Financial year 2025-2026
1 month agoNotice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026
1 month agoNotice of 79th Annual General Meeting and Annual Report for the financial year 2025-2026
1 month agoIntimation of Cut-Off Date for E voting Book Closure and Record date for Dividend
1 month agoIntimation of Cut-Off Date for E voting Book Closure and Record date for Dividend
1 month agoPublication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September 2026 through VC/OAVM
1 month agoPublication of Newspaper Advertisement- 79th Annual General Meeting to be held on 17th September 2026 through VC/OAVM
1 month agoTranscript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026
1 month agoTranscript of Earnings Conference Call on Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30-06-2026
1 month agoPublication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoPublication of Unaudited Standalone and Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoAudio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoAudio recording of Earnings Conference Call on Unaudited Standalone & Consolidated Financial Results for the quarter ended 30-06-2026
1 month agoThe Board of Directors in its Meeting held today i.e. 28th July 2026 has considered and approved1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February 2027 to 14th February 2032 subject to the approval of the shareholders in the ensuing AGM.2. Appointment of Mr. Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company w.e.f. 28th July 2026
1 month agoThe Board of Directors in its Meeting held today i.e. 28th July 2026 has considered and approved1. Re-appointment of Ms. Aditi Panandikar as the Managing Director of the Company for the period of 5 years commencing from 15th February 2027 to 14th February 2032 subject to the approval of the shareholders in the ensuing AGM.2. Appointment of Mr. Sudhir Kadam as Senior Management Personnel designated as Sr. Vice President (Human Capital) of the Company w.e.f. 28th July 2026
1 month agoUnaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with Limited Review Report
1 month agoUnaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with Limited Review Report
1 month agoPursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 28th July 2026 has inter-alia considered and approved Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.
1 month agoPursuant to the Regulation 30 read with Schedule III and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Board of Directors of the Company at its Meeting held today i.e. 28th July 2026 has inter-alia considered and approved Unaudited Standalone and Consolidated Financial Results for the Quarter Ended 30th June 2026 along with the Limited Review Report with unmodified opinion on the aforesaid Unaudited Financial Results.
1 month agoIntimation of Earnings Conference Call on Unaudited Financial Results for Quarter ended 30th June 2026
2 months agoIntimation of Earnings Conference Call on Unaudited Financial Results for Quarter ended 30th June 2026
2 months agoIndoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended 30th June 2026.
2 months agoIndoco Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2026 inter alia to consider and approve The Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended 30th June 2026.
2 months agoAttached the certificate issued by MUFG Intime India Private Limited Registrar & Transfer Agent of the Company confirming compliance under Reg 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended 30-06-2026
2 months agoAttached the certificate issued by MUFG Intime India Private Limited Registrar & Transfer Agent of the Company confirming compliance under Reg 74(5) of SEBI (D&P) Regulations 2018 for the quarter ended 30-06-2026
2 months agoAnnual reports
Concalls & investor presentations
Jul 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Jul 2025
ConcallPresentation
May 2025
ConcallPresentation
Jan 2025
ConcallPresentation
Oct 2024
Jul 2024
ConcallPresentation
May 2024
Jan 2024
ConcallPresentation
Oct 2023
ConcallPresentation
Jul 2023
ConcallPresentation
May 2023
ConcallPresentation
Jan 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation